6 Biotechnology Stocks Moving In Tuesday's Pre-Market Session


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Gainers

Acceleron Pharma, Inc. (NASDAQ:XLRN) stock moved upwards by 59.8% to $84.49 during Tuesday's pre-market session. The most recent rating by Citigroup, on January 22, is at Buy, with a price target of $75.00.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Vaxart, Inc. (NASDAQ:VXRT) stock rose 34.9% to $0.87.

Cocrystal Pharma, Inc. (NASDAQ:COCP) stock surged 33.0% to $1.09.

 

Losers

Novavax, Inc. (NASDAQ:NVAX) shares decreased by 9.9% to $7.66 during Tuesday's pre-market session.

Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares declined 9.8% to $3.70.

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) shares decreased by 6.9% to $0.21.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Pre-Market OutlookMarketsMoversTrading IdeasBiotechnology Stocks Pre-Market MoversTop Gainers